Join the Breast Cancer - Adjuvant group to help and get support from people like you.
Breast Cancer - Adjuvant News (Page 7)
SABCS: Active Monitoring Noninferior to Guideline Care for Ductal Carcinoma in Situ
FRIDAY, Dec. 13, 2024 – For patients with ductal carcinoma in situ (DCIS), active monitoring (AM) is noninferior to guideline-concordant care (GCC) that involves surgery with or without adjuvant...
'Watch and Wait' May Equal Active Treatment for Early DCIS Breast Cancers, Studies Find
FRIDAY, Dec. 13, 2024 – A “watch-and-wait” strategy might be the best option for some women with early-stage, low-risk breast cancer. According to two new studies presented Thursday at the San Ant...
Low-Dose Oral Minoxidil Effective for Alopecia in Breast Cancer
THURSDAY, Dec. 12, 2024 – Low-dose oral minoxidil (LDOM) is effective for alopecia in patients with breast cancer, according to a letter to the editor published online Dec. 3 in the Journal of the...
2004 to 2021 Saw Increase in Distant-Stage Breast Cancer Incidence
THURSDAY, Dec. 12, 2024 – During 2004 to 2021, there was an increase in distant-stage breast cancer incidence rates at presentation, according to a study published online Dec. 10 in Radiology. R....
SABCS: Imlunestrant Tied to Improved PFS for ER-Positive, HER2-Negative Breast Cancer With ESR1 Mutations
THURSDAY, Dec. 12, 2024 – For patients with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negative advanced breast cancer, imlunestrant leads to significantly...
Women With Cancer Can Safely Use Rogaine to Curb Hair Loss
WEDNESDAY, Dec. 11, 2024 – Women worried about losing their locks during chemotherapy can safely take hair-loss drugs during breast cancer care, a new study says. Minoxidil - the active ingredient...
Women With Cancer Can Safely Use Rogaine to Curb Hair Loss
WEDNESDAY, Dec. 11, 2024 – Women worried about losing their locks during chemotherapy can safely take hair-loss drugs during breast cancer care, a new study says. Minoxidil - the active ingredient...
More Women Are Being Diagnosed With Breast Cancer at Later Stages
TUESDAY, Dec. 10, 2024 – More breast cancers are being detected later in women, giving the tumors a chance to spread and become life-threatening, a new study finds. This increase in late-stage...
Adding Previous Screening Mammogram Images Improves Cancer Prediction
MONDAY, Dec. 9, 2024 – Five-year breast cancer (BC) risk prediction is improved with the addition of previous screening mammogram images beyond static models, according to a study published online...
AI Reads Multiple Mammograms to Help Predict Breast Cancer Risk
FRIDAY, Dec. 6, 2024 – A new AI can help identify women at higher risk for developing breast cancer by tracking changes in breast tissue, a new study shows. The AI compares women’s own mammograms o...
New Therapeutic Vaccine Gives Hope Against an Aggressive Breast Cancer
THURSDAY, Nov. 14, 2024 – An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests. The vaccine appears to...
Neoantigen DNA Vaccines Safe, Induce Response in Triple-Negative Breast Cancer
THURSDAY, Nov. 14, 2024 – Neoantigen DNA vaccines are safe and capable of inducing neoantigen-specific immune responses in patients with triple-negative breast cancer, according to a study published...
Inavolisib + Palbociclib-Fulvestrant Improves Survival in Advanced Breast Cancer
THURSDAY, Oct. 31, 2024 – Inavolisib plus palbociclib-fulvestrant yields significantly longer progression-free survival than placebo plus palbociclib-fulvestrant in patients with PIK3CA-mutated,...
Lack of Insurance Could Mean Later Cancer Diagnoses for Black, Hispanic Americans
WEDNESDAY, Oct. 30, 2024 – A lack of health insurance coverage raises the risk that cancers among Black and Hispanic Americans will be caught too late, a new study suggests. Being uninsured accounts...
Multigene Signature Can Help Tailor Chemo for Operable Triple-Negative Breast Cancer
WEDNESDAY, Oct. 30, 2024 – For patients with operative triple-negative breast cancer, a multigene signature can help tailor adjuvant chemotherapy, according to a study published online Oct. 23 in...